MaxCyte (MXCT) CFO awarded 375,000 employee stock options at $0.6762

Rhea-AI Filing Summary

MAXCYTE, INC. Chief Financial Officer Parmeet Ahuja received a grant of employee stock options covering 375,000 shares of Common Stock. The options have an exercise price of $0.6762 per share and expire on March 29, 2036.

According to the vesting schedule, 25% of the shares underlying this option vest on March 30, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, contingent on continued service. Following this grant, Ahuja holds 375,000 stock options directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ahuja Parmeet

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	375,000	$0.00	--

Holdings After Transaction: Employee Stock Option (right to buy) — 375,000 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 375,000 options Exercise price: $0.6762 per share Vesting cliff: 25% on March 30, 2027 +3 more

6 metrics

Option grant size 375,000 options Employee stock option grant to CFO Parmeet Ahuja

Exercise price $0.6762 per share Strike price for employee stock options

Vesting cliff 25% on March 30, 2027 Initial vesting of option grant

Remainder vesting 75% over 36 months Monthly vesting after March 30, 2027

Expiration date March 29, 2036 Option term end date

Post-grant holdings 375,000 options Total options held after transaction

Key Terms

Employee Stock Option (right to buy), vesting, exercise price, expiration date, +1 more

5 terms

Employee Stock Option (right to buy) financial

"security_title: Employee Stock Option (right to buy)"

vesting financial

"shares underlying this option shall vest on March 30, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

exercise price financial

"conversion_or_exercise_price: 0.6762"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2036-03-29T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

underlying security financial

"underlying_security_title: Common Stock"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ahuja Parmeet

(Last) (First) (Middle)

C/O MAXCYTE, INC.

9713 KEY WEST AVENUE, SUITE 400

(Street)

ROCKVILLE MARYLAND 20850

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MAXCYTE, INC. [ MXCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$0.6762	03/30/2026		A		375,000		(1)	03/29/2036	Common Stock	375,000	$0	375,000	D

Explanation of Responses:

1. Twenty-five percent (25%) of the shares underlying this option shall vest on March 30, 2027, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

	/s/ Parmeet Ahuja	04/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did MXCT CFO Parmeet Ahuja receive in this Form 4 filing?

Parmeet Ahuja, CFO of MXCT, received an employee stock option grant for 375,000 shares of Common Stock. These options give the right to buy shares at a fixed price if vesting and other conditions are satisfied.

What is the exercise price of the new MXCT stock options?

The employee stock options granted to MXCT CFO Parmeet Ahuja have an exercise price of $0.6762 per share. This is the price at which he can buy shares once the options vest and are exercised, subject to the plan’s terms.

How do the MXCT CFO’s 375,000 options vest over time?

For MXCT, 25% of the options granted to CFO Parmeet Ahuja vest on March 30, 2027. The remaining 75% vest in 36 equal monthly installments afterward, conditioned on his continued service with the company through each vesting date.

When do the newly granted MXCT stock options expire?

The employee stock options granted to MXCT CFO Parmeet Ahuja expire on March 29, 2036. After this expiration date, any unexercised portion of the options can no longer be used to buy shares under this grant.

How many MXCT stock options does the CFO hold after this grant?

Following this grant, MXCT CFO Parmeet Ahuja holds 375,000 employee stock options directly. These options relate to an equal number of shares of Common Stock, subject to vesting and the terms of the award agreement.